Beyond Air, Inc. (XAIR) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Beyond AirĀ® Reports Financial ResultsĀ for Third Quarter of Fiscal Year 2024
February 12, 2024 4:05 PM ESTCommercial demand for LungFit® PH increasing; manufacturing of upgraded devices is ramping up to meet growing demand
PMA supplement for the expansion of LungFit PH label to include cardiac surgery accepted for filing and under substantive review by the FDA
U.S. pilot trial of LungFit® PRO to treat viral community acquired pneumonia (VCAP) underway; trial will extend over two seasons; the pivotal study remains on track for Winter 2025/26
Phase 1 Study evaluating Beyond Cancers ultra-high concentration nitric oxide (UNO) in advanced, R/R... More



